Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The concern is theoretical and mechanistic: Dihexa's proposed action is potentiation of hepatocyte growth factor (HGF) signaling at the c-Met receptor, a growth, proliferation, and angiogenesis pathway that is dysregulated in several cancers
This matters because many products marketed as "GLP-1 patches" do not contain a GLP-1 receptor agonist at all
Globally, it is projected that over 191 million people will be affected by it by 2030, with around 56 million experiencing vision-threatening stages of the disease
Archived from the original on March 30, 2022
)
US$ 25.44
US$ 26.28
US$ 21.99
US$ 27.93
